Trogarzo

Product manufactured by Theratechnologies Inc.

Application Nr Approved Date Route Status External Links
BLA761065 None Intravenous None Google , Wikipedia , PubMed , DailyMed , Raw OpenFDA , ECHA , ToxNet , JECFA , FAO , 21 CFR

Indications and Purposes

1 Indications And Usage Trogarzo, In Combination With Other Antiretroviral(S), Is Indicated For The Treatment Of Human Immunodeficiency Virus Type 1 (Hiv-1) Infection In Heavily Treatment-Experienced Adults With Multidrug Resistant Hiv-1 Infection Failing Their Current Antiretroviral Regimen. Trogarzo, A Cd4-Directed Post-Attachment Hiv-1 Inhibitor, In Combination With Other Antiretroviral(S), Is Indicated For The Treatment Of Human Immunodeficiency Virus Type 1 (Hiv-1) Infection In Heavily Treatment-Experienced Adults With Multidrug Resistant Hiv-1 Infection Failing Their Current Antiretroviral Regimen.

All Formulated Excipients (0 Total)

None

Active Ingredients ( 1 Total)

Name Structure ZINC ID(s)
1. Ibalizumab

Comments